LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 93 filers reported holding LYELL IMMUNOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43,000 | -25.9% | 29,184 | +61.2% | 0.00% | – |
| Q2 2023 | $58,000 | +152.2% | 18,104 | +87.0% | 0.00% | – |
| Q1 2023 | $23,000 | -68.9% | 9,680 | -55.0% | 0.00% | – |
| Q4 2022 | $74,000 | +393.3% | 21,519 | +921.3% | 0.00% | – |
| Q3 2022 | $15,000 | +150.0% | 2,107 | +116.3% | 0.00% | – |
| Q2 2022 | $6,000 | -87.0% | 974 | -89.3% | 0.00% | – |
| Q1 2022 | $46,000 | +15.0% | 9,114 | +76.1% | 0.00% | – |
| Q4 2021 | $40,000 | -2.4% | 5,174 | +83.9% | 0.00% | – |
| Q3 2021 | $41,000 | – | 2,813 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 20,162,332 | $29,638,628 | 28.72% |
| Orland Properties Ltd | 15,093,969 | $22,188,134 | 11.75% |
| Foresite Capital Management IV, LLC | 8,784,813 | $12,913,675 | 7.17% |
| MIC Capital Management UK LLP | 1,740,569 | $2,558,636 | 0.58% |
| Alphabet Inc. | 5,865,125 | $8,621,733 | 0.55% |
| HSG Holding Ltd | 3,045,997 | $4,477,616 | 0.48% |
| Clarius Group, LLC | 399,168 | $586,777 | 0.06% |
| CAXTON ASSOCIATES LP | 198,477 | $291,761 | 0.04% |
| XTX Topco Ltd | 114,720 | $168,638 | 0.03% |
| BBR PARTNERS, LLC | 164,041 | $241,140 | 0.03% |